Today, Homrich & Berg Reached $252,000 position of Clorox Co. (CLX)

Today, Homrich & Berg Reached $252,000 position  of Clorox Co. (CLX)

Homrich & Berg decreased its position in shares of Clorox Co. (NYSE:CLX) by 4.4% during the third quarter, Holdings Channel reports. The fund owned 2,012 shares of the company’s stock after selling 92 shares during the period. Homrich & Berg’s holdings in Clorox were worth $252,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently modified their holdings of CLX. DAVENPORT & Co LLC boosted its position in shares of Clorox by 3.4% in the second quarter. DAVENPORT & Co LLC now owns 3,039 shares of the company’s stock worth $421,000 after buying an additional 99 shares during the last quarter. Gateway Investment Advisers LLC boosted its position in shares of Clorox by 1.2% in the second quarter. Gateway Investment Advisers LLC now owns 11,646 shares of the company’s stock worth $1,612,000 after buying an additional 137 shares during the last quarter. Mutual of Omaha Bank Wealth Management boosted its position in shares of Clorox by 14.6% in the second quarter. Mutual of Omaha Bank Wealth Management now owns 2,350 shares of the company’s stock worth $226,000 after buying an additional 300 shares during the last quarter. Franklin Street Advisors Inc. NC boosted its position in shares of Clorox by 3.4% in the second quarter. Franklin Street Advisors Inc. NC now owns 25,378 shares of the company’s stock worth $3,512,000 after buying an additional 843 shares during the last quarter. Finally, Chevy Chase Trust Holdings Inc. boosted its position in shares of Clorox by 0.9% in the second quarter. Chevy Chase Trust Holdings Inc. now owns 131,886 shares of the company’s stock worth $18,251,000 after buying an additional 1,190 shares during the last quarter. 69.90% of the stock is owned by institutional investors.

Shares of Clorox Co. (NYSE:CLX) traded up 1.27% during trading on Friday, reaching $116.95. The company’s stock had a trading volume of 263,708 shares. Clorox Co. has a 12 month low of $111.24 and a 12 month high of $140.47. The firm has a market cap of $15.06 billion, a PE ratio of 23.54 and a beta of 0.36. The company’s 50 day moving average price is $117.89 and its 200 day moving average price is $127.70.

Clorox (NYSE:CLX) last released its earnings results on Wednesday, November 2nd. The company reported $1.36 EPS for the quarter, missing the consensus estimate of $1.42 by $0.06. Clorox had a return on equity of 250.82% and a net margin of 11.27%. The business had revenue of $1.44 billion for the quarter, compared to analyst estimates of $1.24 billion. During the same period in the prior year, the business earned $1.32 EPS. The company’s revenue for the quarter was up 3.8% on a year-over-year basis. On average, equities analysts predict that Clorox Co. will post $5.32 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 10th. Investors of record on Wednesday, January 25th will be paid a dividend of $0.80 per share. The ex-dividend date of this dividend is Monday, January 23rd. This represents a $3.20 annualized dividend and a yield of 2.77%. Clorox’s dividend payout ratio is currently 64.26%.

A number of brokerages have recently weighed in on CLX. Goldman Sachs Group Inc. restated a “neutral” rating and issued a $130.00 target price on shares of Clorox in a research note on Thursday, August 4th. Citigroup Inc. raised their target price on Clorox from $134.00 to $144.00 and gave the company a “neutral” rating in a research note on Monday, August 8th. Zacks Investment Research upgraded Clorox from a “hold” rating to a “buy” rating and set a $148.00 target price for the company in a research note on Monday, August 8th. B. Riley restated a “neutral” rating and issued a $109.00 target price on shares of Clorox in a research note on Tuesday, August 9th. Finally, Jefferies Group restated a “hold” rating on shares of Clorox in a research note on Wednesday, August 3rd. Two equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has issued a buy rating to the company. The stock has an average rating of “Hold” and an average target price of $127.30.

In related news, EVP Laura Stein sold 38,882 shares of the firm’s stock in a transaction that occurred on Friday, September 2nd. The stock was sold at an average price of $131.69, for a total transaction of $5,120,370.58. Following the completion of the sale, the executive vice president now owns 48,501 shares of the company’s stock, valued at $6,387,096.69. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Jon M. Balousek sold 5,136 shares of the firm’s stock in a transaction that occurred on Monday, August 29th. The stock was sold at an average price of $131.14, for a total value of $673,535.04. Following the sale, the senior vice president now directly owns 15,384 shares of the company’s stock, valued at approximately $2,017,457.76. The disclosure for this sale can be found here. Corporate insiders own 0.74% of the company’s stock.

About Clorox

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Related posts

Leave a Comment